Gout

Study Evaluates Characteristics, Comorbidities, and Kidney Function of Patients With Uncontrolled Gout Receiving Pegloticase

In this study presented at the EULAR 2021 Virtual Congress, researchers examined the demographics and comorbidities of patients with uncontrolled gout receiving pegloticase.

Impact of Uncontrolled Gout on Quality of Life and Importance of Open Dialogue With Patients

For Arthritis Awareness Month and Gout Awareness Day 2021, Suneet Grewal, MD, provides a deeper insight into the impact of uncontrolled gout on the quality of life of patients and the importance of having an open dialogue.

Sodium-Glucose Cotransporter-2 Inhibitors Linked to Reduced Risk for Gout

Researchers studied the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and gout, using a cohort study design and a symmetry analysis.

Safety and Efficacy Data of Gout Flare Prophylaxis Analyzed in Patients With Chronic Kidney Disease

The review was aimed at describing the current literature on the efficacy and safety of gout flare prophylaxis and therapy in patients with chronic kidney disease.

Rates of Alcohol Use Disorder Hospitalization Increased Among Patients With Gout, RA, Fibromyalgia, Osteoarthritis, and Low Back Pain

The incidence, time trends, and outcomes of alcohol use disorder hospitalizations in patients with gout, rheumatoid arthritis, fibromyalgia, osteoarthritis, and low back pain were examined.

Urate Transporter Variants Associated With Transition From Asymptomatic Hyperuricemia to Gout

Researchers examined the genetic variants associated with the transition from hyperuricemia to gout.

Proinflammatory Cytokines Elevated in Patients With Intercritical Gout, and Linked to MSU Deposition Size and CV Risk Factors

Researchers studied subclinical inflammation in intercritical gout and its association with the size of monosodium urate crystal deposition and cardiovascular risk factors.

Pegloticase Use for Uncontrolled Gout in the Dialysis Population Described

New study is the first to characterize pegloticase use in the dialysis population.

Comorbidity Onset, Not Flare Patterns, Vary Among Morbidity Clusters in Patients With Gout

Researchers evaluated the onset of comorbidities and flare patterns, based on baseline comorbidity clusters in patients with gout.

Pegloticase Immunogenicity Reduced With Concomitant Mycophenolate Mofetil Use in Refractory Gout

Researchers evaluated the effect of mycophenolate mofetil on the efficacy of pegloticase in patients with refractory gout.